This website uses cookies to enhance the user experience.
NORGESPLASTER AS

NORGESPLASTER AS995 011 727

Process industry
Limited company
Granlivegen 21 4707 VENNESLA, Norge

NORGESPLASTER AS

startsida - norgesplaster.no
Velkommen til Norgesplaster - Sår og skadebehandling siden 1938

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Links

Organization

Chairman of the board
Years since formation
14 years
since Jan 16, 2010
Type
Limited company
VAT registered
Yes
Number of employees
53

Ownership

Number of shares and share classes
8,000,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2023
178,968,675
NOK
Annual total result 2023
4,920,938
NOK
Total equity 2023
18,498,966
NOK
Last update: Nov 21, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-
Board Member-
Alternate Member-
Alternate Member-
Alternate Member-
Board Member-
Alternate Member-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
L
LUNDEN REGNSKAP AS
Accountant-
Last update: Jan 16, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
8,000,000
100 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
178,968,675
192,806,572
190,450,352
Annual Total Result
4,920,938
9,642,314
13,355,035
Total assets
83,800,883
93,155,323
89,264,872
Total liabilities
65,301,917
74,725,884
71,180,893
Total equity
18,498,966
18,429,439
18,083,978

P&L

Year202320222021
Total operating income
178,968,675
192,806,572
190,450,352
Total operating costs
171,028,623
180,622,630
172,292,477
Operating result
7,940,052
12,183,943
18,157,875
Financial income/costs
-1,617,362
181,520
-530,245
Profit before tax
6,322,690
12,365,462
17,627,631
Total tax & extraordinary income/cost
1,401,752
2,723,148
4,272,596
Annual Total Result
4,920,938
9,642,314
13,355,035

Balance overview

Year202320222021
Total fixed assets
11,303,306
10,723,079
11,893,550
Total current assets
72,497,576
82,432,243
77,371,321
Total assets
83,800,883
93,155,323
89,264,872
Short term debt
29,583,504
46,520,118
65,748,758
Long term debt
35,718,413
28,205,766
5,432,135
Total liabilities
65,301,917
74,725,884
71,180,893
Contributed capital
17,358,493
17,358,493
17,358,493
Retained earnings
1,140,473
1,070,945
725,485
Total equity
18,498,966
18,429,439
18,083,978
Total equity and liabilities
83,800,883
93,155,323
89,264,872

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations